• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终产物(AGE)与糖尿病:病因、后果,还是二者皆有?

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

机构信息

Department of Geriatrics, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Curr Diab Rep. 2014 Jan;14(1):453. doi: 10.1007/s11892-013-0453-1.

DOI:10.1007/s11892-013-0453-1
PMID:24292971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3903318/
Abstract

Despite new and effective drug therapies, insulin resistance (IR), type 2 diabetes mellitus (T2D) and its complications remain major medical challenges. It is accepted that IR, often associated with over-nutrition and obesity, results from chronically elevated oxidant stress (OS) and chronic inflammation. Less acknowledged is that a major cause for this inflammation is excessive consumption of advanced glycation end products (AGEs) with the standard western diet. AGEs, which were largely thought as oxidative derivatives resulting from diabetic hyperglycemia, are increasingly seen as a potential risk for islet β-cell injury, peripheral IR and diabetes. Here we discuss the relationships between exogenous AGEs, chronic inflammation, IR, and T2D. We propose that under chronic exogenous oxidant AGE pressure the depletion of innate defense mechanisms is an important factor, which raises susceptibility to inflammation, IR, T2D and its complications. Finally we review evidence on dietary AGE restriction as a nonpharmacologic intervention, which effectively lowers AGEs, restores innate defenses and improves IR, thus, offering new perspectives on diabetes etiology and therapy.

摘要

尽管有新的和有效的药物治疗方法,但胰岛素抵抗(IR)、2 型糖尿病(T2D)及其并发症仍然是主要的医学挑战。人们普遍认为,IR 通常与营养过剩和肥胖有关,是由慢性氧化应激(OS)和慢性炎症引起的。不太被认可的是,这种炎症的一个主要原因是过量摄入标准西方饮食中的晚期糖基化终产物(AGEs)。AGEs 曾被认为主要是糖尿病高血糖产生的氧化衍生物,但越来越多的证据表明,AGEs 是胰岛β细胞损伤、外周 IR 和糖尿病的潜在风险因素。在这里,我们讨论了外源性 AGEs、慢性炎症、IR 和 T2D 之间的关系。我们提出,在慢性外源性氧化剂 AGE 压力下,先天防御机制的耗竭是一个重要因素,这增加了炎症、IR、T2D 及其并发症的易感性。最后,我们回顾了饮食 AGE 限制作为一种非药物干预的证据,它可以有效降低 AGEs、恢复先天防御并改善 IR,从而为糖尿病的病因和治疗提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/283cab751d1c/nihms545356f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/26c1ddba62cc/nihms545356f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/e54dad15e497/nihms545356f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/fb3b925c0c9b/nihms545356f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/cba1c4adaf2d/nihms545356f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/283cab751d1c/nihms545356f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/26c1ddba62cc/nihms545356f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/e54dad15e497/nihms545356f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/fb3b925c0c9b/nihms545356f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/cba1c4adaf2d/nihms545356f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94cf/3903318/283cab751d1c/nihms545356f5.jpg

相似文献

1
Advanced glycation end products (AGE) and diabetes: cause, effect, or both?晚期糖基化终产物(AGE)与糖尿病:病因、后果,还是二者皆有?
Curr Diab Rep. 2014 Jan;14(1):453. doi: 10.1007/s11892-013-0453-1.
2
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.口腔内的晚期糖基化终产物(AGEs)通过消耗抗氧化防御物 AGE 受体-1 和 SIRT1 来促进胰岛素抵抗和糖尿病的发生。
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15888-93. doi: 10.1073/pnas.1205847109. Epub 2012 Aug 20.
3
Cereal polyphenols inhibition mechanisms on advanced glycation end products and regulation on type 2 diabetes.谷物多酚对晚期糖基化终产物的抑制机制及对 2 型糖尿病的调控。
Crit Rev Food Sci Nutr. 2024 Sep;64(26):9495-9513. doi: 10.1080/10408398.2023.2213768. Epub 2023 May 24.
4
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.晚期糖基化终产物的限制可改善 2 型糖尿病患者的胰岛素抵抗:AGER1 和 SIRT1 的潜在作用。
Diabetes Care. 2011 Jul;34(7):1610-6. doi: 10.2337/dc11-0091.
5
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction.膳食晚期糖基化终产物在代谢功能障碍中的作用。
Mol Nutr Food Res. 2021 Jan;65(1):e1900934. doi: 10.1002/mnfr.201900934. Epub 2020 Apr 20.
6
AGE restriction in diabetes mellitus: a paradigm shift.糖尿病中的年龄限制:范式转变。
Nat Rev Endocrinol. 2011 May 24;7(9):526-39. doi: 10.1038/nrendo.2011.74.
7
Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.2 型糖尿病成人患者股骨近端的骨微结构、生物力学特性和晚期糖基化终产物。
Bone. 2018 Sep;114:32-39. doi: 10.1016/j.bone.2018.05.030. Epub 2018 May 30.
8
Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease.实验动物研究支持饮食中晚期糖基化终产物在健康和疾病中的作用。
Nutrients. 2021 Sep 29;13(10):3467. doi: 10.3390/nu13103467.
9
Endogenous advanced glycation end products in pancreatic islets after short-term carbohydrate intervention in obese, diabetes-prone mice.短期碳水化合物干预肥胖、糖尿病易感小鼠胰岛内源性晚期糖基化终产物。
Nutr Diabetes. 2019 Mar 11;9(1):9. doi: 10.1038/s41387-019-0077-x.
10
Advanced glycation endproducts in diabetes and diabetic complications.糖尿病及其并发症中的糖基化终产物。
Endocrinol Metab Clin North Am. 2013 Dec;42(4):697-719. doi: 10.1016/j.ecl.2013.07.005.

引用本文的文献

1
Exploring the Interplay Between Glycated Albumin, AGEs, and Inflammation in Old Patients with CKD.探索老年慢性肾脏病患者糖化白蛋白、晚期糖基化终末产物与炎症之间的相互作用
Metabolites. 2025 Aug 1;15(8):515. doi: 10.3390/metabo15080515.
2
Short-term consumption of the modified standard American diet perturbed the metabolic balance and altered DNA damage in MMTV-PyMT transgenic mice.短期食用改良的标准美式饮食扰乱了MMTV-PyMT转基因小鼠的代谢平衡并改变了DNA损伤。
Breast Cancer Res. 2025 Jul 25;27(1):138. doi: 10.1186/s13058-025-02075-w.
3
Correlation between serum advanced glycation end-products and their receptor-mediated oxidative stress and perinatal outcomes in gestational diabetes mellitus.

本文引用的文献

1
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.口腔内的晚期糖基化终产物(AGEs)通过消耗抗氧化防御物 AGE 受体-1 和 SIRT1 来促进胰岛素抵抗和糖尿病的发生。
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15888-93. doi: 10.1073/pnas.1205847109. Epub 2012 Aug 20.
2
Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.西那卡塞对糖尿病肾病患者糖化血红蛋白、炎症和晚期糖基化终产物的影响。
Clin J Am Soc Nephrol. 2012 Jun;7(6):934-42. doi: 10.2215/CJN.12891211. Epub 2012 Mar 29.
3
妊娠期糖尿病患者血清晚期糖基化终产物及其受体介导的氧化应激与围产期结局的相关性
World J Diabetes. 2025 Jun 15;16(6):104177. doi: 10.4239/wjd.v16.i6.104177.
4
Association between metabolic health indicators and cardiorespiratory fitness in urban young and middle-aged population: a retrospective cross-sectional study.城市中青年人群代谢健康指标与心肺适能的关联:一项回顾性横断面研究
Front Endocrinol (Lausanne). 2025 May 21;16:1489152. doi: 10.3389/fendo.2025.1489152. eCollection 2025.
5
gene polymorphism (rs1800625) and type 1 diabetes mellitus: A potential new model for early diagnosis and risk prediction.基因多态性(rs1800625)与1型糖尿病:早期诊断和风险预测的潜在新模型
Narra J. 2025 Apr;5(1):e1603. doi: 10.52225/narra.v5i1.1603. Epub 2025 Jan 30.
6
Endothelial dysfunction in cardiovascular diseases: mechanisms and in vitro models.心血管疾病中的内皮功能障碍:机制与体外模型
Mol Cell Biochem. 2025 Apr 21. doi: 10.1007/s11010-025-05289-w.
7
Association Between Tissue Accumulation of Skin Autofluorescence, Disease, and Exercise Capacity in Older Adults.老年人皮肤自发荧光的组织蓄积、疾病与运动能力之间的关联
Int J Mol Sci. 2025 Mar 23;26(7):2913. doi: 10.3390/ijms26072913.
8
Causal relationships between dietary factors and spinal diseases: a univariable and multivariable Mendelian randomization study.饮食因素与脊柱疾病之间的因果关系:一项单变量和多变量孟德尔随机化研究。
Front Nutr. 2025 Mar 14;12:1437484. doi: 10.3389/fnut.2025.1437484. eCollection 2025.
9
Association between lipoprotein(a) and diabetic peripheral neuropathy in patients with type 2 diabetes: a meta-analysis.2型糖尿病患者脂蛋白(a)与糖尿病周围神经病变的关联:一项荟萃分析。
Diabetol Metab Syndr. 2025 Mar 4;17(1):76. doi: 10.1186/s13098-025-01621-y.
10
Relationship Between Advanced Glycation End Products Tissue Accumulation and Frailty in Patients Undergoing Cardiac Rehabilitation.心脏康复患者晚期糖基化终末产物组织蓄积与衰弱的关系
Cardiol Res. 2025 Feb;16(1):44-52. doi: 10.14740/cr2010. Epub 2025 Jan 21.
Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study.
糖毒素和自身抗体是 1 型糖尿病的环境决定附加预测因子:一项双胞胎和人群研究。
Diabetes. 2012 May;61(5):1192-8. doi: 10.2337/db11-0971. Epub 2012 Mar 6.
4
Advanced glycation end products are direct modulators of β-cell function.晚期糖基化终产物是β细胞功能的直接调节剂。
Diabetes. 2011 Oct;60(10):2523-32. doi: 10.2337/db10-1033. Epub 2011 Sep 12.
5
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.晚期糖基化终产物的限制可改善 2 型糖尿病患者的胰岛素抵抗:AGER1 和 SIRT1 的潜在作用。
Diabetes Care. 2011 Jul;34(7):1610-6. doi: 10.2337/dc11-0091.
6
AGE restriction in diabetes mellitus: a paradigm shift.糖尿病中的年龄限制:范式转变。
Nat Rev Endocrinol. 2011 May 24;7(9):526-39. doi: 10.1038/nrendo.2011.74.
7
Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes?母体传递和食物来源的糖基化终产物:一种使年轻人易患糖尿病的因素?
Diabetes Care. 2010 Oct;33(10):2232-7. doi: 10.2337/dc10-1058. Epub 2010 Jul 13.
8
Advanced glycation end products in foods and a practical guide to their reduction in the diet.食品中的晚期糖基化终产物及其饮食中减少摄入的实用指南。
J Am Diet Assoc. 2010 Jun;110(6):911-16.e12. doi: 10.1016/j.jada.2010.03.018.
9
Effects of combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合降脂治疗效果。
N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14.
10
AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.AGER1 通过蛋白激酶 C 依赖性调节内皮细胞 NADPH 氧化酶依赖的氧化应激:对血管疾病的影响。
Am J Physiol Cell Physiol. 2010 Mar;298(3):C624-34. doi: 10.1152/ajpcell.00463.2009. Epub 2009 Dec 2.